Skip to main content

Table 3 Characterization of the different formulations of NBs

From: Exploring the relationship between autophagy and Gefitinib resistance in NSCLC by silencing PDLIM5 using ultrasound-targeted microbubble destruction technology

Groups

Size distribution(nm)

PDI

Zeta potential(mV)

Pure NBs

216.30 ± 1.54

0.07

22.63 ± 0.55

siRNA-NBs

223.17 ± 2.23

0.08

− 1.94 ± 3.72